About OptiGen
OptiGen is a Healthcare company based in Ithaca (United States) founded in 1997, and was acquired by Mars in April 2018. Provider of genetic testing services for detecting diseases in dogs. Its chief executive, as recorded, is Jeanette Felix. Its focus areas include Life Sciences, Genomics, Applied Genomics and Veterinary Genomics. Its competitors include Embark Veterinary, AnimalBiome and Basepaws; 3 of its 3 listed competitors have raised funding.
Company details
OptiGen was founded in 1997 in Ithaca, United States, within the veterinary genetics sector. Services focused on identifying genetic and inherited diseases in purebred dogs are offered. Breed-specific tests are available, with swabs mailed to customers for sample collection. Online ordering is supported, enabling access to diagnostic information for dog health.
- Headquarters Ithaca, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website optigen.com
- Social Facebook
- Acquired by Mars (Apr 2018)
Investors in OptiGen
OptiGen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Mars.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Grains, legumes, snacks, pet care, and confectionery products are produced. | 1911 | mars.com | Mclean, United States |
Investor details for OptiGen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OptiGen
1 people are tracked at OptiGen (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jeanette Felix | CEO | Leadership |
Complete people profiles for OptiGen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OptiGen
2 dated milestones of OptiGen across 21 years, from founding to its latest funding, stage changes and deals.
- Founded OptiGen is founded.
- Exit Acquired by Mars.
Competitors of OptiGen
OptiGen has 3 listed competitors in our database, 3 of them funded. They include Embark Veterinary, AnimalBiome and Basepaws.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| embarkvet.com | 2015 | Austin, United States | $93.97M | Proivder of DNA test kits for dogs that enable dog owners to provide better pet care | ||
| animalbiome.com | 2016 | San Francisco, United States | $25.88M | 52 | Animal microbiome diagnostics services for pet care are offered. | |
| basepaws.com | 2016 | Mountain View, United States | $250,000 | Provider of genetic testing for cats |
Detailed competitors of OptiGen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of OptiGen
Websites that share an audience with OptiGen (optigen.com).
Websites whose visitors overlap most with OptiGen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
masshistology.com | masshistology.com | 100% | – | ||
biogal.co.il | biogal.co.il | 100% | – | ||
vetgen.com | vetgen.com | 97% | – | ||
offa.org | offa.org | 97% | #10,258,217 | – | |
caninegeneticdiseases.net | caninegeneticdiseases.net | 97% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for OptiGen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as OptiGen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Optigen
Complete news archive for OptiGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OptiGen
OptiGen was founded in 1997.
OptiGen is headquartered in Ithaca, United States. It is registered at Ithaca, New York, United States.
Jeanette Felix is the CEO of OptiGen, as recorded in our data.
OptiGen was founded in 1997 in Ithaca, United States, within the veterinary genetics sector. Services focused on identifying genetic and inherited diseases in purebred dogs are offered. Breed-specific tests are available, with swabs mailed to customers for sample collection. Online ordering is supported, enabling access to diagnostic information for dog health.
OptiGen's top competitors include Embark Veterinary, AnimalBiome and Basepaws.
OptiGen has 1 investor. Key investors include Mars.
Yes. OptiGen was acquired by Mars in April 2018.